Corticotroph tumor progression after bilateral adrenalectomy (Nelson's syndrome): systematic review and expert consensus recommendations.
Martin ReinckeAdriana AlbaniGuillaume AssieIrina BancosThierry BrueMichael BuchfelderOlivier ChabreFilippo CeccatoAndrea DanieleMario DetomasGuido Di DalmaziAtanaska ElenkovaJames FindlingAshley B GrossmanCelso E Gomez-SanchezAnthony P HeaneyJuergen HoneggerNiki KaravitakiAndré LacroixEdward R LawsMarco LosaMasanori MurakamiJohn Newell-PriceFrancesca Pecori GiraldiLuis G Pérez-RivasRosario PivonelloWilliam E RaineySilviu SbieraJochen SchopohlConstantine A StratakisMarily TheodoropoulouElisabeth F C van RossumElena ValassiSabina ZacharievaGerman RubinsteinKatrin RitzelPublished in: European journal of endocrinology (2021)
We endorse the definition of CTP-BADX/NS as radiological progression or new detection of a pituitary tumor on thin-section MRI. We recommend surveillance by MRI after 3 months and every 12 months for the first 3 years after BADX. Subsequently, we suggest clinical evaluation every 12 months and MRI at increasing intervals every 2-4 years (depending on ACTH and clinical parameters). We recommend pituitary surgery as first-line therapy in patients with CTP-BADX/NS. Surgery should be performed before extrasellar expansion of the tumor to obtain complete and long-term remission. Conventional radiotherapy or stereotactic radiosurgery should be utilized as second-line treatment for remnant tumor tissue showing extrasellar extension.
Keyphrases
- systematic review
- contrast enhanced
- magnetic resonance imaging
- minimally invasive
- clinical evaluation
- coronary artery bypass
- diffusion weighted imaging
- public health
- dengue virus
- early stage
- case report
- squamous cell carcinoma
- magnetic resonance
- stem cells
- rheumatoid arthritis
- surgical site infection
- computed tomography
- coronary artery disease
- atrial fibrillation
- rectal cancer
- bone marrow
- long non coding rna
- real time pcr